The targeted treatment of pan-cancer by messenger RNA (mRNA) vaccine is a hot topic in drug research. A key challenge in mRNA design is the construction of delivery systems called lipid nanoparticles (LNPs), which serve as carriers to deliver mRNA therapies or vaccines to target cells. The preparation and screening of LNPs components involve long cycles and high costs. The targeted treatment of pan-cancer by messenger RNA (mRNA) vaccine is a hot topic in drug research. A key challenge in mRNA design is the construction of delivery systems called lipid nanoparticles (LNPs), which serve as carriers to deliver mRNA therapies or vaccines to target cells. The preparation and screening of LNPs components involve long cycles and high costs. Bio & Medicine Phys.org – latest science and technology news stories
Headlines
